Abstract
Bridging the gap between academia and industry is a key to the success of efforts to promote translation of basic biomedical research into therapeutic applications. This month, two leaders of research institutes that have close associations with the pharma industry discuss the attractions and challenges in working at the academia–industry interface, and the factors that they consider important for success.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Buy this article
- Purchase on SpringerLink
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Rights and permissions
About this article
Cite this article
Life at the interface. Nat Rev Drug Discov 6, 415 (2007). https://doi.org/10.1038/nrd2316
Issue date:
DOI: https://doi.org/10.1038/nrd2316
